ReviewFrontiers in immunology2019

YKL-39 as a Potential New Target for Anti-Angiogenic Therapy in Cancer.

Julia Kzhyshkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.